Rimkus Consulting Group, Inc. Acquires Core Human Factors

Rimkus Consulting Group, Inc. today announced the acquisition of Core Human Factors (“Core HF”), a human factors analysis firm that provides research and guidance on consumer, industrial, and healthcare-related products.

The acquisition provides Rimkus’ Human Factors Practice with an extended suite of services focusing on medical devices and regulatory guidance.

“With 10 acquisitions in the last two years, our aggressive growth strategy will continue in 2022, focusing on areas that drive value for our clients. Core HF’s team brings a medical device lens to our Human Factors Practice. We believe the combination of Core HF and our current Human Factors group will make Rimkus Consulting Group a global leader in the field of Human Factors and we look forward to seeing how our clients will benefit from this unmatched team of experts. We are committed to expanding Rimkus, providing enhanced services, and supporting our team as we drive growth and innovation together,” said Curtis Brown, Chairman and Executive Director, Rimkus Consulting Group, Inc.

“The Core HF team draws on an extraordinary wealth of experience and truly understands how to bring a personal aspect to their work, much like we do at Rimkus. Additionally, their team’s collaborative approach and advanced technology made this an ideal acquisition. Together, we’ll be able to customize the customer experience and continue elevating Rimkus as an industry leader,” said Robert Kocher, President and Chief Executive Officer, Rimkus Consulting Group, Inc.

Core Human Factors’ mission is to apply a human touch to all aspects of user research: serving their clients, connecting with their study participants, collaborating with their co-workers, and improving the usability and safety of products and services. They use a variety of analytical and observational research methods to help companies improve their products at all points in the design lifecycle, from conceptualization through post-market troubleshooting. Their niche is medical and drug delivery devices, and they align their efforts with their clients’ human factors engineering (HFE) programs as team contributors or develop and manage all HFE efforts when requested.

“We’re honored to join the Rimkus family and to work alongside their team of seasoned and established experts. Our two companies are aligned in our shared vision of being a global leader in engineering and technical consulting. Together, we will continue to provide and expand our professional expertise and client service to our valued clients,” said Adam Shames, MBA, Founder and CEO, Core Human Factors.

Since 2020, Rimkus has completed 10 acquisitions worldwide, growing their network to more than 1,200 employees and over 100 offices. Through the acquisitions, Rimkus has enhanced their existing practice areas to stay ahead of their global customers’ requirements and invested in solutions that enable the company to remain a leader.

Rimkus Consulting Group, Inc. is a worldwide provider of forensic engineering and technical consulting services to corporations, insurance companies, law firms, and government agencies.

Rimkus forensic experts assist clients with the responsive and timely resolution of claims and disputes across a wide range of industries.

Rimkus also provides architecture, engineering, and construction services for the built environment, including restoration design, facilities risk assessments, and due-diligence property condition assessments.

For more than 35 years, the company’s professional engineers, architects, scientists, and technical specialists have been recognized for their commitment to service excellence by local, national, and international business communities.

Medical Device News Magazinehttps://infomeddnews.com
Our publication is dedicated to bringing our readers the latest medical device news. We are proud to boast that our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall purpose and objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

he Intracept system, a basivertebral nerve ablation therapy, will be an addition to the Boston Scientific chronic pain portfolio that includes spinal cord stimulation, radiofrequency ablation and an interspinous spacer procedure.
"As Probo Medical has grown, we've seen the value of tailoring our commercial offering to the specific needs of specialists that we serve. Davis Medical provides us with exactly that in the cardiology specialty, with decades of experience and a refined approach to support cardiology practices with the equipment, services and supplies they need to run their practice," said Michael Asmer, CEO of Probo. "Additionally, the Davis Medical team adds significant strength to our footprint in the western US."
“This acquisition will provide a much-needed treatment to patients in need,” said Orlaith Ryan, chief technical officer and co-founder of Shorla Oncology. “It brings a crucial oral treatment to a larger patient population who suffer from cancer and other debilitating illnesses.”
Paragon Medical serves a wide range of specialty applications including orthopedics, minimally invasive surgery, robotic surgery, and drug delivery. Paragon's product portfolio includes single-use and consumable surgical instruments and implantable components sold to a diverse blue-chip customer base of leading medical device manufacturers.
“Time is of the essence during medical emergencies, as we saw in 2022 when EU member states required emergency shipments of Tecovirimat SIGA to treat patients infected with mpox,” said Meridian Medical Technologgies Commercial Head – Injectables & Health Security, Tom Handel. “This joint procurement framework contract, a significant milestone for both Meridian and HERA, reduces the time and effort required to put individual contracts in place with each member state from months to days. There are now multiple paths in Europe for streamlined procurement, allowing member state agencies to get much needed medical countermeasures into the hands of those in need.”

By using this website you agree to accept Medical Device News Magazine Privacy Policy